Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Structural evaluation of a nanobody targeting complement receptor Vsig4 and its cross reactivity

18 Nov 2016

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement system in diseases
Share to Monoclonal and Polyclonal Antibodies Research
Share to T-cell and B-cell Immunology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 27889311
DOI: 10.1016/j.imbio.2016.11.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Structural evaluation of a nanobody targeting complement receptor Vsig4 and its cross reactivityPMID 27889311Read ↗

Multifaceted Activities of Seven Nanobodies against Complement C4bSemantic proximity Read ↗

50 Years of structural immunologySemantic proximity Read ↗

Functional targeting of Glypican-4 by a conformation-specific single-domain antibodySemantic proximity Read ↗

Complement-specific antibodies: Designing novel anti-inflammatoriesSemantic proximity Read ↗

Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodiesSemantic proximity Read ↗

Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodiesSemantic proximity Read ↗

Unique Binding and Stabilization Mechanisms Employed By and Engineered Into NanobodiesSemantic proximity Read ↗

A Comprehensive Review on Therapeutic Potential of NanobodiesSemantic proximity Read ↗

The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeuticsSemantic proximity Read ↗

Rational Engineering of a Minimized Immune Inhibitor with Unique Triple-Targeting PropertiesSemantic proximity Read ↗

Single-Domain Antibodies or Nanobodies: A Class of Next-Generation AntibodiesSemantic proximity Read ↗

GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeuticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.